Traders Sell Shares of Abercrombie & Fitch (ANF) on Strength (ANF)

Investors sold shares of Abercrombie & Fitch (NYSE:ANF) on strength during trading hours on Friday. $21.17 million flowed into the stock on the tick-up and $27.72 million flowed out of the stock on the tick-down, for a money net flow of $6.55 million out of the stock. Of all companies tracked, Abercrombie & Fitch had the 0th highest net out-flow for the day. Abercrombie & Fitch traded up $0.68 for the day and closed at $27.35

ANF has been the subject of a number of analyst reports. Robert W. Baird reissued a “hold” rating on shares of Abercrombie & Fitch in a research report on Tuesday, January 23rd. Jefferies Group boosted their price objective on shares of Abercrombie & Fitch from $14.00 to $17.00 and gave the company a “hold” rating in a research report on Monday, December 18th. B. Riley boosted their price objective on shares of Abercrombie & Fitch from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday, February 27th. Bank of America boosted their price objective on shares of Abercrombie & Fitch from $9.00 to $16.00 and gave the company a “sell” rating in a research report on Wednesday, January 24th. Finally, Morgan Stanley boosted their price objective on shares of Abercrombie & Fitch from $11.00 to $13.00 and gave the company an “underweight” rating in a research report on Thursday, March 8th. Seven analysts have rated the stock with a sell rating, twelve have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $17.57.

How to Become a New Pot Stock Millionaire

The company has a current ratio of 2.49, a quick ratio of 1.66 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $1,816.27, a PE ratio of 42.08, a P/E/G ratio of 2.80 and a beta of 0.90.

Abercrombie & Fitch (NYSE:ANF) last released its quarterly earnings data on Wednesday, March 7th. The apparel retailer reported $1.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.28. Abercrombie & Fitch had a net margin of 0.20% and a return on equity of 4.86%. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the firm earned $0.71 earnings per share. Abercrombie & Fitch’s revenue for the quarter was up 15.2% on a year-over-year basis. analysts expect that Abercrombie & Fitch will post 0.68 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 19th. Shareholders of record on Friday, March 9th were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $0.80 annualized dividend and a yield of 2.93%. Abercrombie & Fitch’s dividend payout ratio is currently 123.08%.

In other Abercrombie & Fitch news, Director Arthur C. Martinez sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, March 8th. The shares were sold at an average price of $23.72, for a total transaction of $474,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Glassman Wealth Services purchased a new position in shares of Abercrombie & Fitch in the fourth quarter valued at $122,000. Lorber David A purchased a new position in shares of Abercrombie & Fitch in the third quarter valued at $126,000. Meadow Creek Investment Management LLC purchased a new position in shares of Abercrombie & Fitch in the fourth quarter valued at $154,000. LMR Partners LLP purchased a new position in shares of Abercrombie & Fitch in the fourth quarter valued at $212,000. Finally, AXA purchased a new position in shares of Abercrombie & Fitch in the fourth quarter valued at $241,000. Institutional investors own 99.46% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3340245/traders-sell-shares-of-abercrombie-fitch-anf-on-strength-anf.html.

About Abercrombie & Fitch

Abercrombie & Fitch Co, through its subsidiaries, operates as a specialty retailer. The Company operates through two segments, Abercrombie and Hollister. It offers knit tops, woven shirts, graphic T-shirts, fleece, sweaters, jeans, woven pants, shorts, outerwear, dresses, intimates, and swimwear; and personal care products and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, Hollister, and Gilly Hicks brand names.

Receive News & Ratings for Abercrombie & Fitch Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abercrombie & Fitch and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cryptonex  24-Hour Volume Hits $1.55 Million
Cryptonex 24-Hour Volume Hits $1.55 Million
Critical Survey: Shoe Carnival  versus Foot Locker
Critical Survey: Shoe Carnival versus Foot Locker
Sleep Number Forecasted to Post Q1 2019 Earnings of $0.63 Per Share
Sleep Number Forecasted to Post Q1 2019 Earnings of $0.63 Per Share
Q4 2018 EPS Estimates for ASML Holding Raised by Analyst
Q4 2018 EPS Estimates for ASML Holding Raised by Analyst
Cubic  PT Raised to $70.00 at Needham & Company LLC
Cubic PT Raised to $70.00 at Needham & Company LLC
Albireo Pharma  Coverage Initiated by Analysts at Jefferies Group
Albireo Pharma Coverage Initiated by Analysts at Jefferies Group


Leave a Reply

© 2006-2018 Ticker Report. Google+.